Back to search results

Energy Healing for Fibromyalgia Study

This study is looking at how Energy Healing affects people with fibromyalgia. Researchers want to see if Energy Healing can change brain connections and reduce pain, compared to a "sham" (inactive) Energy Healing. You might be able to join if you are a woman between 18 and 75 years old, have a fibromyalgia diagnosis, and experience consistent pain. The study aims to enroll 25 participants. We don't know yet if the study is actively recruiting.

Study design
This is an interventional study planning to enroll 25 female participants.
What's involved
You would have assessments at pre-screening, baseline, during the intervention, and at 3- and 6-month follow-ups after treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06552728

The Effects of Energy Healing in Fibromyalgia

Recruiting
NAAges 18–75InterventionalTreatment
University of California, Irvine
~25 participants
Updated 2025-10-24 on ClinicalTrials.gov
What's tested:Energy Healing

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Neural connectivity
Measured over Pre screening, Baseline, Intervention, 3- and 6-month follow ups Post-treatment

Conditions

Fibromyalgia

Explore related trials

Fibromyalgia

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Richard Harris, PhD · PRINCIPAL_INVESTIGATOR · UCI SSIHI

Who to contact

Richard E Harris, PhD
[email protected]
(949) 824-7000
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Female
Over 18 and under 75 years of age.
Fibromyalgia patients must meet the 2016 Fibromyalgia Diagnostic Criteria for the classification of FM.
Mean recalled pain over the last seven days (7-day recall) between 4-10 cm on Visual - - - - Analog Scale (VAS) for pain with no pain free days in the last 2 months and active pain in resting state lying on back.
No contraindications for MRI, such as metal in the body or electrical devices in the body.
Willing to limit the introduction of any new medications or treatment modalities for control of FM symptoms during the study.
Able to travel to the study site to receive MRI, EH, and sham EH sessions up to twice weekly.
Understanding and willing to complete all study procedures.
Capable of giving written informed consent.
Proficient ability to speak, read, and write in english.

Exclusion

EH within the last 6-months.
Have received past treatment from Charlie Goldsmith or know of him or his work.
Contraindications to MRI and fcMRI methods. These may include but are not limited to: surgical clips, surgical staples, metal implants, and certain metallic dental material, claustrophobia, etc. \[Note: a more formal description of contraindications for MRI is present -in our DSM Plan\].
Presence of known past procedures, devices in the body, claustrophobia, or other contraindications for MRI
Presence of a concurrent autoimmune or inflammatory disease such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, etc. that causes pain.
Peripheral neuropathy that interferes with activities of daily living.
Routine daily use of narcotic analgesics or history of substance abuse.
Stimulant medications, such as those used to treat ADD/ADHD (e.g., amphetamine/ dextroamphetamine \[Adderall®\], methylphenidate, dextroamphetamine), or the fatigue associated with sleep apnea or shift work (e.g., modafinil), are excluded.
Concurrent participation in other therapeutic trials.
Pregnant or nursing.
Severe psychiatric illnesses (current schizophrenia, major depression with suicidal ideation).
Active substance abuse disorder in the past 24 months as determined by subject self-report.
Use of PRN over the counter (OTC) pain medications (NSAIDs, etc.) on day of MRI scan.
Use of PRN narcotic pain medication 48 hours prior to MRI scan.
Current active litigation for FM pain.
Any impairment, activity or situation that in the judgment of the Principal Investigator or other team member that would prevent satisfactory completion of the study protocol. This includes unreliable, or inconsistent pain scores as deemed by the principal investigator.

What this trial measures

  • Neural connectivityPre screening, Baseline, Intervention, 3- and 6-month follow ups Post-treatment

    change in brain connectivity of the insula/salience network (SLN), sensory motor network (SMN), and default mode network (DMN) resulting from energy healing (EH) as compared to sham EH.